FDA's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) Grant Program
Food and Drug Administration
Description
The FDA's OMUMS program provides grants to help cover the costs of safety and effectiveness testing needed for FDA approval of drugs for minor animal species and less common uses in major species. Eligible studies can focus on animal safety, drug effectiveness, environmental impact, human food safety, and some manufacturing aspects.
The FDA's OMUMS was established to increase the availability of medications for minor animal species and minor uses in major species. The program offers grants to assist with the costs of safety and effectiveness testing required for FDA approval of MUMS-designated drugs. Eligible studies includ…
Source
Grant ID
PAR-24-216
Agency
Food and Drug Administration
Subcategory/Subagency
Food and Drug Administration
Key Dates
Opportunity Released
May 3, 2024
Eligibility
The following categories of applicants are invited to apply:
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- State Governments
- Higher Education Institutions: Public/State Controlled Institutions of Higher Education
- Higher Education Institutions: Private Institutions of Higher Education
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- For-Profit Organizations: Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- County Governments
- City or Township Governments
- Special District Governments
- Local Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Faith-based or Community-based Organizations
- Regional Organizations
- Non-domestic (non-U.S.) Entities (Foreign Organizations)
Awards & Funding
Award Ceiling
$250,000
Funding Amount
Discretionary
Similar opportunities
- Notice of Funding Opportunity (NOFO) for Clinical Trials of Orphan Products
Department of Health and Human Services
- Notice of Funding Opportunity for Device Development to Treat Substance Use Disorders
National Institutes of Health
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions
National Institutes of Health
- Accelerating Innovative Drug and Device Therapies Translation from Discovery to Early Human Studies
National Institutes of Health
- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
Food and Drug Administration